Clinical Trial Update: A Study of Lurasidone Compared With Placebo for the Treatment of Bipolar I Depression [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing lurasidone to placebo for bipolar I depression has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Depression

Drugs mentioned

• lurasidone (lurasidone)

Snippet

Sponsor: Sumitomo Pharma (Suzhou) Co., Ltd. | Conditions: Bipolar I Depression | Phase 3 | Status: TERMINATED